BCM
IRON icon

BML Capital Management’s Disc Medicine IRON Stock Holding History

BML Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-208,161
Closed -$4.41M – 34
2023
Q1 		$4.41M Sell
208,161
-291,839
-58% -$6.5M 3.81% 12
2022
Q4 		$9.95M Buy
+500,000
New +$24.9M 9.5% 4

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BML Capital Management's IRON Position: Q2 2023 in Review

BML Capital Management sold out of Disc Medicine (IRON) in Q2 2023, closing a stake of 208,161 shares — an estimated $4.41M sold.

BML Capital Management first reported a position in IRON in Q4 2022 and held it in 2 quarters. The position peaked at $9.95M in Q4 2022. 90 funds tracked by Wall St. Rank hold IRON as of Q2 2023.

  • BML Capital Management reported no remaining Disc Medicine position as of Q2 2023 after selling out during the quarter.
  • BML Capital Management sold 208,161 Disc Medicine shares in Q2 2023, an estimated $4.41M.
  • BML Capital Management first reported a position in Disc Medicine in Q4 2022 and held it in 2 quarters.
  • BML Capital Management's Disc Medicine position peaked at $9.95M in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2023.

Based on BML Capital Management's 13F filing for Q2 2023, filed 24 Jul 2023.